NaQuinate : Haoma Medica completes human trial of osteoporosis candidate

Haoma Medica has wrapped up a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as an oral treatment for osteoporosis. The ... Read More